Promotion of acellular dermal matrix resolution in vitro by matrix metalloproteinase-2

Jonathan P Lindman1, Melissa Talbert, Wenyue Zhang

  • 1Division of Otolaryngology, Department of Surgery, and Department of Biostatistics, University of Alabama at Birmingham, 35294-0012, USA.

Abstract

Insights

Matrix metalloproteinases (MMPs), particularly MMP-2, degrade acellular human dermis. Inhibiting MMPs may enhance the longevity of implanted dermal matrices by slowing fibroblast infiltration.

Area of Science:

  • Biomaterials Science
  • Tissue Engineering
  • Dermatology

Background:

  • Acellular human dermis is a common biomaterial used in tissue regeneration.
  • Matrix metalloproteinases (MMPs) are enzymes known to degrade extracellular matrix components.

Purpose of the Study:

  • To investigate the degradation of acellular human dermis by MMPs.
  • To determine the role of MMP-2 in this degradation process.

Main Methods:

  • In vitro evaluation of acellular human dermis degradation using wild-type and MMP-2-deficient fibroblasts.
  • Assessment of matrix degradation and fibroblast infiltration with and without a broad-spectrum MMP inhibitor (GM6001).

Main Results:

  • Wild-type fibroblasts significantly reduced basement membrane thickness compared to controls with GM6001.
  • Fibroblast infiltration was significantly reduced by GM6001.
  • Wild-type fibroblasts degraded the basement membrane and infiltrated the dermis more effectively than MMP-2-deficient fibroblasts.

Conclusions:

  • MMPs, especially MMP-2, appear to play a key role in the resorption of acellular human dermis.
  • Inhibiting MMPs could potentially improve the in vivo performance of implanted dermal matrices by modulating fibroblast activity.